<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Regenerative Medicine]]></title>
    <link>https://www.leadingmarketresearch.com/pharmaceuticals-biotechnology/biotechnology/regenerative-medicine</link>
    <description><![CDATA[Regenerative Medicine]]></description>
    <pubDate>Fri, 10 Apr 2026 06:00:52 +0000</pubDate>
    <generator>Zend_Feed</generator>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Regenerative Medicine Market Report 2023-2033]]></title>
      <link>https://www.leadingmarketresearch.com/regenerative-medicine-market-report-2023-2033</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>The <strong>Regenerative Medicine Market Report 2023-2033</strong>: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.</p>
<p><strong>Growing number of Joint Ventures to fuel market growth</strong><br />
The demand for breakthrough techniques in tissue engineering, cell therapy, and stem cell use is increasing due to the rising prevalence of chronic diseases and clinical trials. Continuous joint ventures, mergers, acquisitions, and other strategic activity by various companies is helping the regenerative medicine market thrive. For instance, in October 2022, Dr. Vanessa Rodriguez Pares and Meso Numismatics, Inc. (MSSV), a biotech and numismatics-focused technology company, partnered with the new STEM LIFE clinic facility. This collaboration aims to promote regenerative medicine&#039;s high standards. Similar to this, Astellas Pharma Inc...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228484"><span class="price">$4,938.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 19 May 2023 11:50:09 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Global Regenerative Medicine Market Analysis &amp; Forecast to 2021; Stem Cells, Tissue Engineering, BioBanking &amp; CAR-T Industries]]></title>
      <link>https://www.leadingmarketresearch.com/global-regenerative-medicine-market-analysis-and-forecast-to-2021-stem-c</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">This report provides a comprehensive overview of the size of the regenerative medicine market, segmentation of the market (stem cells, tissue engineering and CAR-T therapy), key players and the vast potential of therapies that are in clinical trials.  Kelly Scientific analysis indicates that the global regenerative medicine market was worth $18.9 billion in 2016 and will grow to over $53.7 billion by 2021, with a CAGR of 23.3% between this time frame. Within this market, the stem cell industry will grow significantly at a CAGR of over x% and reach $x billion by 2021. Tissue engineering is forecast to grow at a CAGR of x% to 2021 and potentially reach $x billion. This report describes the evolution of such a huge market in 15 chapters supported by over 350 tables and figures in 680 pages.

• An overview of regenerative medicine that includes: stem cells, allogenic and autogenic cells, umbilical cord blood banking, tissue engineering and CAR T therapies.
• Global regenerative medicine market, global breakdown, application breakdown and leading market players 
• Detailed accou...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-195315"><span class="price">$4,900.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 26 Apr 2017 12:43:51 +0000</pubDate>
    </item>
  </channel>
</rss>
